๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Shanghai

3827 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer
NCT06718010Breast Cancer, Age
Fudan University
Observational
120
Shanghai
2024-12-05
Recruiting
Target-specific immunoPET Imaging of Digestive System Carcinoma
NCT06715839Malignancy, Digestive Cancer, Digestive System Neoplasm, Digestive System Carcinoma
RenJi Hospital
Not applicable
400
Shanghai
2024-12-04
Recruiting
Application of a New Surgical Technique in Proximal Gastrectomy: a Prospective, Multicenter Randomized Controlled Study
NCT06679244Gastric Cancer Patients Undergoing Minimally Invasive Gastrectomy
Huashan Hospital
Not applicable
52
Shanghai
2024-12-04
Recruiting
The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy
NCT06746194Hepatocellular Carcinoma (HCC)
Ruijin Hospital
Observational
40
Shanghai
2024-12-03
Recruiting
HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
NCT06587061Pancreatic Cancer
Ruijin Hospital
Phase 2
30
Shanghai
2024-12-03
Active, closed
Real-world Study on Fenestrated Stent for Thoracic Aortic Dissection
NCT07268755Thoracic Aortic Dissection, Thoracic Aortic Disease
Qingyou Meng
Observational
320
Shanghai
2024-12-01
Not yet open
Foldable Capsular Scleral Buckling Versus Vitrectomy in Medium-complex Rhegmatogenous Retinal Detachment Treatment
NCT06610786Rhegmatogenous Retinal Detachment
Eye & ENT Hospital of Fudan University
Not applicable
100
Shanghai
2024-12-01
Recruiting
Shanghai Prospective Registry Study of Ischemic Stroke
NCT07171242Ischemic Stroke
Qiang Dong
Observational
15,000
Shanghai
2024-12-01
Active, closed
A Study on the Assessment of Difficult Weaning in Patients With Acute Respiratory Failure Undergoing Mechanical Ventilation Based on Machine Learning EIT-pendelluft: A Multicenter Retrospective Study.
NCT06756204Acute Respiratory Failure Requiring Intubation
Ruijin Hospital
Observational
216
Shanghai
2024-12-01
Recruiting
Development and Validation of a Risk Prediction Model for De Novo Stress Urinary Incontinence After Pelvic Floor Reconstruction Surgery
NCT07601282Pelvic Organ Prolapse (POP), Stress Urinary Incontinence (SUI)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
382
Shanghai
2024-12-01
Recruiting
Effect of Premedication With Pronase on Mucosal Cleanliness During EGD
NCT06713421Esophageal Cancer, Gastric Cancer
Changhai Hospital
Not applicable
3,000
Shanghai
2024-12-01
Recruiting
Safety and Efficacy of IMPT or IMRT for Breast Cancer
NCT06826885Breast Cancer, Proton Therapy, Intensity Modulated Radiation Therapy, Efficacy and Safety
Ruijin Hospital
Observational
500
Shanghai
2024-12-01
Recruiting
Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer
NCT06684418NSCLC (Non-small Cell Lung Cancer), Artificial Intelligence (AI), Lymphnode Metastasis
Fudan University
Observational
6,000
Shanghai
2024-12-01
Recruiting
The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors
NCT06775080Gastrointestinal Tumors
Huashan Hospital
Phase 2
40
Shanghai
2024-12-01
Not yet open
Effects of Monitoring Blood Pressure During Pregnancy
NCT06217913Birth Weight, Weight Gain Trajectory
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
400
Shanghai
2024-12-01
Recruiting
COLORECTUM+ Digital System for Postoperative Quality Improvement in Colorectal Cancer
NCT06685497Colorectal Carcinoma
RenJi Hospital
Not applicable
236
Shanghai
2024-12-01
Active, closed
A ReaL World Study of DS-8201
NCT06945224Breast Cancer Metastatic, Treatment Efficacy
Fudan University
Observational
300
Shanghai
2024-12-01
By invitation
Risk Model for Metastasis Detection of Neuroblastoma
NCT06703944Neuroblastoma (NB), Prognosis, Bone Marrow Metastasis, Bone Metastases
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
500
Shanghai, Hangzhou, Shenzhen
2024-12-01
Not yet open
ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT
NCT06646666B-cell Non Hodgkin Lymphoma
Ruijin Hospital
Phase 2
35
Shanghai
2024-12-01
Active, closed
Evaluating the Efficacy of Structured Exercise Interventions in Alleviating Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors: a Pilot Study Protocol
NCT06754293Musculoskeletal Symptoms, Breast Cancer, Endocrine Therapy, Aromatase Inhibitors
Fudan University
Not applicable
24
Shanghai
2024-12-01
Recruiting
Real-World Study of Niraparib in First-Line Maintenance Therapy for Advanced Epithelial Ovarian Cancer
NCT07783022Ovarian Cancer
Fudan University
Observational
1,920
Shanghai
2024-12-01
Not yet open
Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL)
NCT06549335Follicular Lymphoma
Ruijin Hospital
Phase 2
66
Shanghai
2024-12-01
Not yet open
MCE Identifying Bleeding Lesions in Patients with Antiplatelet Drugs-Related Acute Non-Hematochezia Gastrointestinal Bleeding
NCT06698874Gastrointestinal Bleeding, Antiplatelet Therapy
Changhai Hospital
Not applicable
204
Qinghai, Shanghai, Xi'an
2024-12-01
Not yet open
First-line Treatment of Advanced/unresectable DDLPS
NCT06694324Dedifferentiated Liposarcoma, Soft Tissue Sarcoma (STS)
Fudan University
Phase 2
49
Shanghai
2024-12-01
Not yet open
Prognostic Study of Prostate Cancer Via Dynamic Change of PSA in Peritoneal Drainage Fluid After Radical Prostatectomy
NCT06608225Prostatic Neoplasms, Prostate-Specific Antigen
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
100
Shanghai
2024-12-01
Not yet open
Evaluating Pharmacogenomics-Based Pharmacotherapy in Real-World Settings for Schizophrenia
NCT06700967Schizophenia Disorder
Shanghai Mental Health Center
Observational
400
Shanghai
2024-12-01
Recruiting
Clinical Research on 68Ga-FAPI PET/CMR in Cardiovascular Diseases
NCT07063043Cardiovascular Diseases (CVD)
Shanghai East Hospital
Observational
40
Shanghai
2024-12-01
Not yet open
Prognostic Study of Via Dynamic Change of dT-DNA in Drainage Fluid After Radical Prostatectomy
NCT06707974Prostatic Neoplasms, ctDNA
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
100
Shanghai
2024-12-01
Recruiting
PSA Versus STN DBS for DT
NCT06752434Dystonic Tremor
Ruijin Hospital
Not applicable
20
Shanghai
2024-12
Not yet open
SHR-1701 Combined with SHR2554 and BP102 for MCRC
NCT06679673Colorectal Cancer Metastatic
Fudan University
Phase 2
20
Shanghai
2024-12
Not yet open
A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors
NCT06724263Recurrent Platinum-resistant Epithelial Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Cervical Cancers, Small Cell Lung Cancer
Tasly Biopharmaceuticals Co., Ltd.
Phase 2
120
Shanghai
2024-12
Not yet open
Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma
NCT06728618Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (SCC), Resectable Oral and Oropharyngeal Squamous Cell Carcinoma, Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Phase 2
28
Shanghai
2024-12
Not yet open
JAK1 Inhibitor Ivarmacitinib Reversing Immunotherapy Resistance in TNBC
NCT06731153Triple Negative Breast Cancer (TNBC), Metastatic Breast Cancer
Fudan University
Phase 2
40
Shanghai
2024-12
Not yet open
AK137 (Bispecific Antibody Targeting CD73 and LAG-3) in Patients With Advanced Malignant Tumors
NCT06691360Advanced Malignant Tumors
Akeso
Phase 1
87
Shanghai
2024-12
Recruiting
Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors
NCT06684327Paget Disease, Extramammary, Rhabdomyosarcoma, Testicular Cancer, Penile Cancer
Fudan University
Phase 2
100
Shanghai
2024-11-30
Not yet open
Oral Topotecan With Toripalimab for Patients With Endometrial Cancer
NCT06548763Endometrial Cancer
Fudan University
Phase 2
30
Shanghai
2024-11-30
Active, closed
Safety and Efficacy of the Surpass Evolve Flow Diverter in Treating Intracranial Aneurysms
NCT06731946Intracranial Arterial Aneurysm
Yibin Fang
Observational
150
Shanghai
2024-11-29
Recruiting
The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases
NCT06730529Thyroid Cancer
Ruijin Hospital
Observational
40
Shanghai
2024-11-29
Recruiting
Exploratory Study on Infection and Immunosenescence Based on an Elderly Clinical Cohort
NCT07672522Immunosenescence
Huashan Hospital
Observational
484
Shanghai
2024-11-29
Recruiting
A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma
NCT06700395Multiple Myeloma
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
136
Shanghai, Chengdu
2024-11-28
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
AstraZeneca
Phase 2
270
Chengdu, Guangzhou, Nanchang, Nanjing, Nantong, Shandong, Shanghai, Tianjin
2024-11-27
Recruiting
A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients
NCT07260305Advanced or Metastatic Solid Tumors
Kangabio AUSTRALIA LTD PTY
Phase 1
57
Beijing, Shanghai
2024-11-27
Recruiting
CD70-targeted immunoPET Imaging of Kidney Cancer
NCT06680089Urologic Neoplasms, Urogenital Neoplasms, Kidney Neoplasms, Neoplasms
RenJi Hospital
Phase 2
300
Shanghai
2024-11-27
Active, closed
A Randomized Controlled Trial to Improve the Therapeutic Effect of Robot-assisted Radical Prostatectomy (RARP) Using Indocyanine Green Fluorescence Imaging
NCT06748742Prostate CA
Liu Cheng
Observational
50
Shanghai
2024-11-26
Recruiting
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib
NCT06668103Non-Small Cell Lung Cancer With EGFR Mutation
Abbisko Therapeutics Co, Ltd
Phase 2
54
Hefei, Harbin, Wuhan, Changchun, Shanghai
2024-11-25
Recruiting
A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss
NCT06722170DFNB9, Congenital Hearing Loss, Hearing Loss, Sensorineural
Yilai Shu
Not applicable
24
Zhengzhou, Shanghai
2024-11-22
Recruiting
Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer
NCT06601283Pancreatic Cancer
Fudan University
Phase 2/3
50
Shanghai
2024-11-22
Recruiting
The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICU
NCT06742060Diabetes Insipidus, Neurohypophyseal, Copeptin Blood Levels, Copeptin, Neurosurgical Intervention
Children's Hospital of Fudan University
Observational
100
Shanghai
2024-11-22
Recruiting
Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic Cancer
NCT06598033Pancreatic Cancer
Fudan University
Phase 2/3
50
Shanghai
2024-11-22
Recruiting
A Study of HRS-4642 Monotherapy or in Combination With Adebrelimab in the Treatment of Advanced Biliary Tract Tumors.
NCT06620848Biliary Tract Cancer
Shanghai Zhongshan Hospital
Phase 2
49
Shanghai
2024-11-21
Active, closed
Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer
NCT06693128Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Ruijin Hospital
Phase 2
80
Chengdu, Shanghai, Yantai
2024-11-21
Recruiting
Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors
NCT06666270Advanced Solid Cancer, Metastatic Solid Tumor, Ovarian Cancer, Breast Cancer
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Phase 1
30
Zhengzhou, Shanghai
2024-11-21
Recruiting
Micturition Desire-Relaxation Training Device for Lower Urinary Tract Dysfunction in Children
NCT07000656Daytime Urinary Incontinence, Urinary Frequency, Lower Urinary Tract Dysfunction, Primary Nocturnal Enuresis
Shanghai Children's Medical Center
Not applicable
200
Shanghai
2024-11-20
Recruiting
Ivonescimab in the Treatment of Multiple Advanced Tumors
NCT06683846Pheochromocytoma/Paraganglioma, Rhabdomyosarcoma, Paget Disease, Extramammary, Renal Angiomyolipoma
Fudan University
Phase 2
400
Shanghai
2024-11-20
Recruiting
A Survey on Growth Development in Children After Liver Transplantation
NCT07574398Growth, Development in Pediatric Liver Transplant Recipients
RenJi Hospital
Observational
275
Shanghai
2024-11-20
Recruiting
Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer
NCT06659042Lung Cancer, Non-Small Cell
Shanghai Chest Hospital
Phase 2
32
Shanghai
2024-11-20
Recruiting
Immunobridging/Maintenance Therapy Versus Non-bridging Therapy in CAR-T Therapy for Low-risk R/R B-NHL
NCT06695013B-NHL, CART Therapy
Ruijin Hospital
Phase 2
144
Shanghai
2024-11-20
Recruiting
ImmunoPET Imaging of Pancreatic Cancer
NCT06602037Neoplasms Pancreatic
RenJi Hospital
Not applicable
90
Shanghai
2024-11-20
By invitation
Haemodialysis Alters Hypercoagulability of Blood in Dialysis Patients
NCT07098676Healthy Individuals (Controls), Vascular Surgery Patients With Acute Thrombosis, Dialysis Patients
Ai Peng
Observational
900
Shanghai
2024-11-20
Recruiting
Physiological Effects and Safety of Continuous High-frequency Oscillatory Ventilation in Mechanical Ventilation Patients
NCT06662630Atelectasis, Acute Respiratory Distress Syndrome, VAP - Ventilator Associated Pneumonia
Shanghai Zhongshan Hospital
Not applicable
30
Shanghai
2024-11-19
Recruiting
Physiological Effects and Safety of Continuous High-frequency Oscillatory Ventilation in ICU Patients
NCT06702813Atelectasis, Postoperative, Hypoxia, Critical Illness
Shanghai Zhongshan Hospital
Not applicable
45
Shanghai
2024-11-19
Recruiting
Selective Neck Dissection Versus Modified Neck Dissection in PTC
NCT06554652Thyroid Cancer
Fudan University
Phase 3
250
Shanghai
2024-11-19
Recruiting
An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line Setting
NCT06749886Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
22
Shanghai
2024-11-19
Recruiting
Evaluation of Two Cell-based Assays for Diagnosing MOG-IgG Associated Disorders
NCT06617962Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders
Huashan Hospital
Observational
240
Shanghai
2024-11-18
Recruiting
Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma
NCT06652243Hepatocellular Carcinoma (HCC)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
12
Shanghai
2024-11-18
Recruiting
A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor
NCT06682117Treatment, Neoantigen, Vaccine, Solid Tumor Cancer
Fudan University
Not applicable
9
Shanghai
2024-11-15
Active, closed
A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia
NCT06637501Chronic Lymphocytic Leukemia
BeOne Medicines
Phase 2
94
Fuzhou, Zhengzhou, Changzhou, Nanjing, Shanghai, Hangzhou
2024-11-14
Not yet open
Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC
NCT06699459Biliary Tract Carcinoma
Sir Run Run Shaw Hospital
Phase 2
76
Fuzhou, Guangzhou, Shanghai, Hangzhou
2024-11-14
Active, closed
A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy
NCT06642909Primary Membranous Nephropathy
BioRay Pharmaceutical Co., Ltd.
Phase 2
135
Shanghai
2024-11-13
Recruiting
A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
NCT06499350Advanced Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase 1/2
33
Shanghai
2024-11-13
Not yet open
EOCRCPred: an AI Model to Predict Survival in EOCRC Patients After Surgery
NCT06690606Colorectal Cancer
Shanghai University of Traditional Chinese Medicine
Observational
250
Shanghai
2024-11-12
Recruiting
Prophylactic Intervention for Relapse Prevention Post-Allogeneic Transplantation in Very High-Risk MDS Patients Based on IPSS-M Stratification
NCT06612944Myelodysplastic Syndromes, Adult
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
40
Shanghai
2024-11-12
Recruiting
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
NCT07433283Tumor, Solid, Lung Cancer, Pancreas Cancer, Thyroid Cancer
Sichuan Enray Pharmaceutical Sciences Company
Phase 1/2
54
Beijing, Hunan, Chongqing, Fuzhou, Haikou, Heilongjiang, Shanghai, Chengdu
2024-11-12
Recruiting
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4ฮฑ SrRNA in Treating Metastatic CRC Patients
NCT06621173Metastatic Colorectal Cancer (mCRC)
Shanghai Changzheng Hospital
Phase EARLY_PHASE1
9
Shanghai
2024-11-12
Recruiting
An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer
NCT06560112Recurrent Ovarian Cancer
Akeso
Phase 2
172
Shanghai
2024-11-12
Active, closed
A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)
NCT06537414Chronic Hepatitis B Virus Infection, Hepatitis B
GlaxoSmithKline
Phase 2
283
Beijing, Chengdu, Guangzhou, Shanghai
2024-11-11
Active, closed
A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above
NCT06645665Respiratory Syncytial Virus Infections
Shenzhen Shenxin Biotechnology Co., Ltd
Phase 1
240
Shanghai, Kunming
2024-11-11
Recruiting
HER2-PET: Predicting T-DXd Efficacy and HER2 Heterogeneity
NCT07586215Breast Cancer Metastatic
Fudan University
Observational
100
Shanghai
2024-11-11
By invitation
GCB-002 in Treatment of Patients With Rett Syndrome
NCT06739434RETT Syndrome With Proven MECP2 Mutation
Genecombio Ltd.
Not applicable
6
Shanghai
2024-11-11
Recruiting
Model-Driven Individualized Transcranial Direct Current Stimulation for the Treatment of Insomnia Disorders
NCT06671457Insomnia
Zhen Wang
Not applicable
40
Shanghai
2024-11-10
Recruiting
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Hepatobiliary Malignancy
NCT06597539Hepatobiliary Malignancy
Ruijin Hospital
Observational
40
Shanghai
2024-11-09
Recruiting
Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer
NCT06468280Gastric Cancer, GastroEsophageal Cancer
Shanghai Zhongshan Hospital
Phase 2
84
Shanghai
2024-11-08
Recruiting
A Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation
NCT06667544KRAS G12D Mutation
Ranok Therapeutics (Hangzhou) Co., Ltd.
Phase 1/2
152
Nanning, Zhengzhou, Wuhan, Hangzhou, Shanghai
2024-11-08
Recruiting
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4ฮฑ srRNA in Treating Advanced ICC Patients
NCT06583993Intrahepatic Cholangiocarcinoma
Shanghai Changzheng Hospital
Phase EARLY_PHASE1
9
Shanghai
2024-11-07
Active, closed
Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors
NCT06849921Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors, Hematologic Disease
Ruijin Hospital
Not applicable
200
Shanghai
2024-11-07
Recruiting
Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer
NCT06755684EGFR, Non-Small Cell Lung Cancer, Locally Advanced Non-Small Cell Lung Cancer, Pemetrexed
Peng Zhang
Phase 2
60
Shanghai
2024-11-07
Recruiting
Prospective Observational Study on Comprehensive Effects of PEEK Cranioplasty and Titanium Cranioplasty After DC๏ผˆRECEPT-DC๏ผ‰
NCT05416684Skull Defect
RenJi Hospital
Observational
358
Shanghai
2024-11-07
Active, closed
A Study of SI-B001+SI-B003 Combined With Platinum-based Chemotherapy as First-line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT06668961Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
48
Shanghai
2024-11-07
Active, closed
An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE)
NCT06594094Duchenne Muscular Dystrophin (DMD)
HuidaGene Therapeutics Co., Ltd.
Phase EARLY_PHASE1
4
Shanghai
2024-11-06
Recruiting
89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study
NCT06750419Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
82
Beijing, Hangzhou, Hubei, Shanghai, Suzhou, Tianjin, Wuxi, Zhejiang
2024-11-06
Recruiting
Efficacy and Safety of ENN0403 in Patients At High Risk for Acute Kidney Injury Following Elective Cardiac Surgery
NCT06632613Cardiac Surgery Associated - Acute Kidney Injury
EnnovaBio
Phase 2
200
Shanghai
2024-11-05
Not yet open
A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
NCT06672393Psoriasis
Hansoh BioMedical R&D Company
Phase 3
375
Shanghai
2024-11-04
Recruiting
All Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancer๏ผša Multi-center, Multi-cohort Phase II Trial
NCT06636981Triple Negative Breast Cancer (TNBC)
Fudan University
Phase 2
129
Shanghai
2024-11-04
Active, closed
A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis
NCT06640257Psoriatic Arthritis
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
208
Shanghai
2024-11-04
Recruiting
Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
NCT06596694Gastrointestinal Cancer
Merck Sharp & Dohme LLC
Phase 1/2
180
Hefei, Fuzhou, Xiamen, Guangzhou, Nanning, Zhengzhou, Shanghai, Taiyuan
2024-11-03
Active, closed
Cola Ingestion for Esophageal Bolus Impaction
NCT06652620Esophageal Cancer
Fudan University
Not applicable
50
Xiamen, Yangzhou, Jingdezhen, Shanghai
2024-11-01
Not yet open
Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer
NCT06648200Small Cell Lung Cancer Extensive Stage, Small Cell Lung Cancer Recurrent
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
100
Shanghai
2024-11-01
Recruiting
TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC
NCT06676449Esophageal Carcinoma, Radiotherapy, Immunotherapy
Fudan University
Phase 3
432
Shanghai
2024-11-01
Recruiting
Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BC
NCT06500208Breast Cancer
Shanghai Jiao Tong University School of Medicine
Phase 2
48
Shanghai
2024-11-01
By invitation
Perioperative Treatment Outcomes of Early NSCLC
NCT06610240NSCLC
Shanghai Chest Hospital
Observational
500
Shanghai
2024-11-01
Rows per page Showing 2001–2100 of 3827
Previous 19 20 21 22 23 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=21

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,827 of those studies with a site in Shanghai.

How many clinical trials are recruiting in Shanghai?

2,393 of the 3,827 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 737 have not yet opened recruitment, 588 are active but closed to new participants, and 109 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.